☰ Navigation Tabs
A6-A11 diselenide glargine insulin
NMR Experiment Experiment Type Sample Contents Solvent Ionic Strength pH Pressure Temperature (K) Spectrometer 1 2D 1H-13C HSQC 0.3 mM Se-glargine insulin 100% D2O/10% d4-acetic acid 0.5 mM 2.1 1 atm 298 Bruker AVANCE NEO 700 2 2D 1H-15N HSQC 0.3 mM Se-glargine insulin 90% H2O/10% D2O/10% d4-acetic acid 0.5 mM 2.1 1 atm 298 Bruker AVANCE NEO 700 3 2D 1H-1H NOESY 0.3 mM Se-glargine insulin 90% H2O/10% D2O/10% d4-acetic acid 0.5 mM 2.1 1 atm 298 Bruker AVANCE NEO 700 4 2D 1H-1H NOESY 0.3 mM Se-glargine insulin 100% D2O/10% d4-acetic acid 0.5 mM 2.1 1 atm 298 Bruker AVANCE NEO 700 5 2D 1H-1H TOCSY 0.3 mM Se-glargine insulin 90% H2O/10% D2O/10% d4-acetic acid 0.5 mM 2.1 1 atm 298 Bruker AVANCE NEO 700 6 2D 1H-1H TOCSY 0.3 mM Se-glargine insulin 100% D2O/10% d4-acetic acid 0.5 mM 2.1 1 atm 298 Bruker AVANCE NEO 700
NMR Spectrometer Information Spectrometer Manufacturer Model Field Strength 1 Bruker AVANCE NEO 700
NMR Refinement Method Details Software simulated annealing X-PLOR NIH
NMR Ensemble Information Conformer Selection Criteria structures with the least restraint violations Conformers Calculated Total Number 100 Conformers Submitted Total Number 20 Representative Model 1 (closest to the average)
Computation: NMR Software # Classification Version Software Name Author 1 processing TopSpin 4.05 Bruker Biospin 2 chemical shift assignment Sparky Goddard 3 peak picking Sparky Goddard 4 structure calculation X-PLOR NIH Schwieters, Kuszewski, Tjandra and Clore